Novel immunotherapeutic approaches to the treatment of urothelial carcinoma

Type I-polarized BRAF-pulsed dendritic cells induce antigen-specific CD8+ T cells that impact BRAF-mutant murine melanoma

Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination

Exploiting the Immunogenic Potential of Cancer Cells for Improved Dendritic Cell Vaccines

Current status and perspectives of immune-based therapies for hepatocellular carcinoma

Effective Clinical Responses in Metastatic Melanoma Patients after Vaccination with Primary Myeloid Dendritic Cells

Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms‘ Tumor 1 in Patients with Advanced Colorectal Cancer

A phase I/IIa study of adjuvant immunotherapy with tumour antigen-pulsed dendritic cells in patients with hepatocellular carcinoma

Clinical research on dendritic cell vaccines to prevent postoperative recurrence and metastasis of liver cancer

Therapeutic Vaccination With Dendritic Cells Loaded With Autologous HIV Type 1-Infected Apoptotic Cells